Choroidal thinning can be assessed through facial video analysis
- PMID: 40235808
- PMCID: PMC11994566
- DOI: 10.21037/qims-24-2146
Choroidal thinning can be assessed through facial video analysis
Abstract
Background: Different features of skin are associated with various medical conditions and provide opportunities to evaluate and monitor body health. This study created a strategy to assess choroidal thinning through the video analysis of facial skin.
Methods: Videos capturing the entire facial skin were collected from 48 participants with age-related macular degeneration (AMD) and 12 healthy individuals. These facial videos were analyzed using video-based trans-angiosomes imaging photoplethysmography (TaiPPG) to generate facial imaging biomarkers that were correlated with choroidal thickness (CT) measurements. The CT of all patients was determined using swept-source optical coherence tomography (SS-OCT).
Results: The results revealed the relationship between relative blood pulsation amplitude (BPA) in three typical facial angiosomes (cheek, side-forehead, and mid-forehead) and the average macular CT (r=0.48, P<0.001; r=-0.56, P<0.001; r=-0.40, P<0.01). When considering a diagnostic threshold of 200 µm for CT, the newly developed facial video analysis tool effectively distinguished between cases of choroidal thinning and normal cases, yielding areas under the curve of 0.75, 0.79, and 0.69.
Conclusions: These findings shed light on the connection between choroidal blood flow and facial skin hemodynamics, which suggests the potential for predicting vascular diseases through widely accessible skin imaging data.
Keywords: Photoplethysmography; blood pulsation amplitude (BPA); choroidal thinning prediction; facial skin video; swept-source optical coherence tomography (SS-OCT).
Copyright © 2025 AME Publishing Company. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-24-2146/coif). R.K.W. serves as a Deputy Editor of Quantitative Imaging in Medicine and Surgery. R.K.W. discloses intellectual property owned by the Oregon Health and Science University and the University of Washington. R.K.W. also receives research support from Research to Prevent Blindness, Inc., Carl Zeiss Meditec Inc., Colgate Palmolive Company, and Estee Lauder Inc. He is a consultant to Carl Zeiss Meditec and Cyberdontics. G.G. receives research support from Carl Zeiss Meditec, Inc. He and the University of Miami co-owned a patent that is licensed to Carl Zeiss Meditec, Inc. P.J.R. received research support from Research to Prevent Blindness, Inc., Carl Zeiss Meditec, Inc., and Gyroscope Therapeutics. P.J.R. and the University of Miami co-own a patent that is licensed to Carl Zeiss Meditec, Inc. P.J.R. is also a consultant for Abbvie, Annexon, Apellis, Boehringer-Ingelheim, Carl Zeiss Meditec, Chengdu Kanghong Biotech, Genentech/Roche, InflammX Therapeutics, Ocudyne, Regeneron Pharmaceuticals, and Unity Biotechnology. He also has equity interest in Apellis, InflammX, Ocudyne, and Valitor. The other authors have no conflicts of interest to declare.
Figures




References
LinkOut - more resources
Full Text Sources